How medication and treatment changed my HDFN-affected infant’s life

Photo shows doctor listening to chest of baby boy with stethoscope
Doctor listening to chest of baby boy with stethoscope
This experience taught us about making informed decisions about HDFN treatment and the importance of providers who truly care about their patients.
Navigating the healthcare system, especially for rare conditions, can be challenging. That's why it's so important to choose a provider you can trust.

After my child received an emergency blood transfusion due to complications with hemolytic disease of the fetus and newborn (HDFN), we had follow-up appointments with two different Hematologists to find the best fit for our family. We chose Dr. Trinh Nguyen at Texas Children’s Hospital because of her enthusiasm and detailed plan to help my child, Benelli. Dr. Nguyen suggested weekly visits to check Benelli’s hematology and decide if she needed a blood transfusion based on lab results.

The hospital had a transfusion center on-site, making it easier on the days Benelli needed transfusions. About two weeks after her first transfusion, she needed another. Dr. Nguyen noticed her hemoglobin levels dropping and quickly gave her a second transfusion after birth. During this visit, Dr. Nguyen recommended a medication called Darbepoetin alfa, which may reduce the need for more transfusions.

Sadly, our insurance initially denied the medication. It was hard to understand why they wouldn’t approve a medicine that could help our baby. Dr. Nguyen tried appealing, but it was denied again. Thankfully, Dr. Nguyen talked to the hospital leaders, and they agreed to give Benelli the Darbepoetin alfa without charging it to our account—a kind gesture that turned out to be a blessing.

The day we found out Benelli would get the medicine without a cost, she needed another transfusion. But after receiving Darbepoetin alfa, she never needed another transfusion. Dr. Nguyen kept filing appeals, and eventually, insurance covered the cost of the drug. But waiting for approval could have meant more transfusions for Benelli.

This journey showed us how crucial it is to have caring and dedicated healthcare professionals like Dr. Nguyen. Navigating the healthcare system, especially for rare conditions and new treatments, can be challenging. Looking back, the frustrations of denials and appeals were outweighed by the relief we felt as Benelli thrived post Darbepoetin alfa. This experience taught us about making informed decisions, seeking proactive medical care and the importance of healthcare providers who truly care about their patients.

Going through HDFN and its treatment taught us the value of making informed decisions, seeking proactive medical care and having healthcare providers who go the extra mile. Dr. Trinh Nguyen’s dedication made a huge difference in navigating a rare medical condition and finding innovative treatments that changed our lives.